Table 2 Cytotoxicity and protein kinase inhibition of different solvent extracts of A. bracteosa

Nh

63.33 ± 5.77^bc

91.40 ± 0.23

31.5 ± 1.5

> 20

61.14 ± 0.70^c

8.95 ± 0.20

10.00 ± 1.0

16.00 ± 1.0^e

12.5

Nh-Ea

73.33 ± 5.77^b

112.37 ± 1.20

45.57 ± 1.00^c

> 20

38.43 ± 0.78

> 20

6.67 ± 0.58

9.67 ± 0.58

100

Nh-E

53.33 ± 5.77^cd

153.33 ± 1.12

35.87 ± 0.85

> 20

57.37 ± 0.67^d

19.10 ± 0.50

6.67 ± 0.58

15.00 ± 1.0^e

25

C

93.33 ± 5.77^a

85.40 ± 0.26

26.67 ± 0.91

> 20

60.50 ± 0.50^c

9.50 ± 0.28

6.67 ± 0.58

10.67 ± 0.58^fg

50

Ea

43.33 ± 5.77

> 200

14.17 ± 1.35

> 20

61.53 ± 0.35^c

8.63 ± 0.30

6.67 ± 0.58

9.33 ± 0.58

100

C-M

53.33 ± 5.77^cd

> 200

18.27 ± 2.91

> 20

20.60 ± 0.30

> 20

9.00 ± 1.0

12.00 ± 1.0^f

100

Ea-M

63.33 ± 5.77^bc

137.37 ± 0.55

19.63 ± 2.87

> 20

31.45 ± 0.15

> 20

9.00 ± 1.0

30.00 ± 1.0^b

12.5

A

63.33 ± 5.77^bc

123.83 ± 0.95

33.13 ± 1.70

> 20

54.71 ± 0.25^e

19.80 ± 0.20

–

12.00 ± 1.0^f

100

M

93.33 ± 5.77^a

110 ± 0.75

45.37 ± 1.56^c

> 20

56.63 ± 0.20^d

19.76 ± 0.20

28 ± 1.0

40.00 ± 1.0^a

12.5

A-M

63.33 ± 5.77^bc

123.5 ± 0.92

77.63 ± 1.33^b

4.9 ± 0.20

25.90 ± 0.19

> 20

15.00 ± 1.0

25.0 ± 1.0^c

50

A-E

93.33 ± 5.77^a

123.4 ± 0.89

48.27 ± 3.00^c

> 20

49.80 ± 0.67

> 20

6.67 ± 0.58

12.0 ± 1.0^f

100

E

96.67 ± 5.77^a

46.91 ± 0.19

20.8 ± 1.90

> 20

37.40 ± 0.30

> 20

6.33 ± 0.58

7.67 ± 0.58

–

A-Dw

93.33 ± 5.77^a

52.63 ± 1.11

47.43 ± 2.16^c

> 20

29.60 ± 0.80

> 20

7.00 ± 1.0

15.00 ± 1.0^e

50

M-Dw

93.33 ± 5.77^a

64.93 ± 1.40

30.47 ± 1.95

> 20

63.07 ± 0.40^b

8.68 ± 0.25

–

12.00 ± 1.0^f

100

Dw

33.33 ± 5.77

> 200

36.7 ± 1.15

> 20

46.83 ± 0.25

> 20

7.00 ± 1.0

–

–

Doxorubicin

96.67 ± 5.77^a

5.63 ± 0.25

98.37 ± 0.15^a

5.30 ± 0.20

5-Florouracil

99.2 ± 0.92^a

5.13 ± 0.13

Vincristine

99.33 ± 0.83^a

8.24 ± 0.12

Surfactin

20 ± 1.0^d

DMSO

–

–

–

–